CN103157092A

CN103157092A - Drug for treating schizophrenia

Info

Publication number: CN103157092A
Application number: CN2013101114147A
Authority: CN
Inventors: 徐道慧
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-03-22
Filing date: 2013-03-22
Publication date: 2013-06-19

Abstract

The invention relates to a drug for treating schizophrenia. The drug is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 pats of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of herba aristolochiae, 10-20 parts of radices sileris, 15-30 parts of oriental wormwood, 20-30 parts of tetrapanax papyriferus, 1-20 parts of cuscuta chinensis, 1-20 parts of lophatherum gracile, 10-25 parts of lalang grass rhizome, 10-30 parts of chrysanthemum, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of flos farfarae, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of radix bupleuri, 10-20 parts of corydalis amabilis, 15-25 parts of cortex mori radicis, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All the components of the drug for treating schizophrenia in the invention are natural materials, so the drug is good in safety, clear in curative effect and suitable for large-scale promotion clinically.

Description

A kind ofly treat schizoid medicament

Technical field

The present invention relates to field of medicaments, relate in particular to a kind of schizoid medicament for the treatment of.

Background technology

Schizophrenia is a kind of psychiatric department disease, it is a kind of lasting, common chronic great mental sickness, the most serious a kind of in psychosis, with basic individual character, the division of thinking, emotion, behavior, the inharmonious of ergasia and environment is a modal psychosis of class of principal character, many between twenty and fifty morbidities, and then affect behavior and emotion.The main sign of schizophrenia is considered to basic thinking structure and cognitive chipping.This phenomenon of dissociating it is believed that and can cause the thinking form disorders and cause differentiating inherent and external experience.Suffer from schizoid people and may oneself represent that hallucination is arranged, perhaps, other people can find that their performance is affected by hallucination.The patient also may express obvious vain hope conviction.At present, the demand for the schizoid medicine for the treatment of increases day by day.

Summary of the invention

The purpose of this invention is to provide a kind of schizoid medicament for the treatment of.

in order to realize purpose of the present invention, the invention provides a kind of schizoid medicament for the treatment of, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Artemisiae Scopariae 15-30 part, Medulla Tetrapanacis 20-30 part, Semen Cuscutae 1-20 part, Herba Lophatheri 1-20 part, Rhizoma Imperatae 10-25 part, Flos Chrysanthemi 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Flos Farfarae 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.

preferably, the schizoid medicament for the treatment of of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts of Herba Artemisiae Scopariaes, 27 parts of Medulla Tetrapanaciss, 18 parts of Semen Cuscutae, 17 parts of Herba Lophatheris, 23 parts of Rhizoma Imperataes, 21 parts of Flos Chrysanthemis, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Flos Farfaraees, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.

More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.

Whole compositions of the schizoid medicament for the treatment of of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.

The specific embodiment

Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.

Embodiment decoction of the present invention

take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Artemisiae Scopariae 24 grams, Medulla Tetrapanacis 27 grams, Semen Cuscutae 18 grams, Herba Lophatheri 17 grams, Rhizoma Imperatae 23 grams, Flos Chrysanthemi 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Flos Farfarae 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Semen Euryales 16 grams and Flos Rhododendri Mollis 24 grams, add 2000 milliliters of entry, in being housed, heated 4 hours under 80 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.

Experimental example

Diagnostic criteria:

Draft according to " psychiatry " schizoid diagnostic criteria: verbal auditory ballucination appears in (1) repeatedly; (2) significantly loosening of association, splitting of thought, speech are discontinuous, or poverty of content of thought; (3) thought is inserted the people, is withdrawn, is sent out, thinking interrupts, or forced thinking; (4) passive, controlled, or known clearly experience; (5) vain hope of primary delusion (comprising delusional perception, delusional mood) or other absurdities; (6) thinking logic perversion, morbid symbolic thinking, or neologism; (7) parathymia, or significantly apathy; (8) tension syndrome, strange behavior, or unwise behavior; (9) obvious hypobulia or shortage.

Exclusion standard:

Get rid of organic mental disorders, and psychoactive drug substance and non-addiction material caused by mental disorder.The schizophrenic patients of not yet alleviating if suffer from again aforementioned two class diseases in this, should be diagnosed side by side.

Close case 60 examples of the standard of stating of selector, male's 30 examples wherein, 45 years old mean age, women's 30 examples, 51 years old mean age.

Therapeutic scheme

Use the decoction for preparing in embodiment to treat, every day 2 times, each oral 50 milliliters.Treating 6 months is 1 course for the treatment of.

Efficacy assessment standard

According to " psychiatry " (the Shen fishing. psychiatry. Beijing: the People's Health Publisher, 2006:725-726) related standards, clinical efficacy drafted be produce effects: symptom fully or basic the disappearance, insight exists; Effectively: symptom disappears substantially, and the part insight exists; Invalid: symptom has no to alleviate, and insight does not recover.

Therapeutic outcome:

Through the treatment of a course for the treatment of, all patients all meets the standard of produce effects.

Claims

1. treat schizoid medicament for one kind, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Artemisiae Scopariae 15-30 part, Medulla Tetrapanacis 20-30 part, Semen Cuscutae 1-20 part, Herba Lophatheri 1-20 part, Rhizoma Imperatae 10-25 part, Flos Chrysanthemi 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Flos Farfarae 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.

2. the schizoid medicament for the treatment of according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts of Herba Artemisiae Scopariaes, 27 parts of Medulla Tetrapanaciss, 18 parts of Semen Cuscutae, 17 parts of Herba Lophatheris, 23 parts of Rhizoma Imperataes, 21 parts of Flos Chrysanthemis, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Flos Farfaraees, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.

3. the schizoid medicament for the treatment of according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.